Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Lamotrigine in Translational Neuroscience: Mechanistic In...
2025-12-31
This thought-leadership article explores the multifaceted role of Lamotrigine—an advanced sodium channel blocker and 5-HT inhibitor—in shaping translational neuroscience and cardiovascular research. By integrating mechanistic detail, high-throughput experimental strategies, and the latest blood-brain barrier (BBB) modeling innovations, we provide actionable guidance for researchers aiming to optimize CNS drug workflows and accelerate bench-to-bedside breakthroughs.
-
Lamotrigine as a Translational Research Catalyst: Mechani...
2025-12-30
This thought-leadership article examines Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) as a high-purity sodium channel blocker and 5-HT inhibitor, blending mechanistic detail with experimental guidance for translational CNS and cardiac researchers. It contextualizes Lamotrigine’s role within emerging high-throughput blood-brain barrier (BBB) models, offers actionable workflow optimization, and charts a strategic path forward for clinical translation, all while highlighting APExBIO’s rigorous product standards.
-
Cisapride (R 51619): Precision Phenotyping and Next-Gen C...
2025-12-29
Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and hERG potassium channel inhibitor, is revolutionizing cardiac electrophysiology research. This article uniquely focuses on integrating deep learning and iPSC-derived cardiomyocytes for advanced cardiac safety and phenotypic screening applications.
-
Amitriptyline HCl in Neuropharmacology: Optimizing BBB Mo...
2025-12-28
Amitriptyline HCl stands out as a versatile serotonin/norepinephrine receptor inhibitor, powering next-generation blood-brain barrier (BBB) modeling and neurotransmitter pathway studies. This guide delivers hands-on workflows, advanced troubleshooting, and expert insights for maximizing experimental impact in neurodegenerative and mood disorder research.
-
Amitriptyline HCl: Mechanistic Benchmarks for Neuropharma...
2025-12-27
Amitriptyline HCl is a tricyclic serotonin/norepinephrine receptor inhibitor with validated utility in neurotransmitter receptor modulation and blood-brain barrier (BBB) model benchmarking. Its precise pharmacological profile and robust solubility make it a preferred tool for translational neuropharmacology and CNS drug discovery. This article details the compound’s mechanism, experimental parameters, and integration into high-throughput workflows.
-
Perospirone (SM-9018 Free Base): Mechanism, Benchmarks, a...
2025-12-26
Perospirone (SM-9018 free base) is a potent atypical antipsychotic agent for schizophrenia research, acting as a 5-HT2A and D2 receptor antagonist and 5-HT1A partial agonist. Recent findings show it also inhibits vascular Kv1.5 channels, expanding its relevance for modeling neuropsychiatric and cardiovascular comorbidities. This dossier details receptor affinities, validated off-target effects, and practical research applications.
-
Cimetidine as a Translational Research Catalyst: Mechanis...
2025-12-25
Explore how Cimetidine's unique partial agonist activity at the H2 receptor, distinct from traditional antagonists, is reshaping translational research in gastrointestinal cancers and beyond. This thought-leadership article navigates mechanistic advancements, experimental best practices, competitive benchmarking, and emerging clinical relevance. Drawing on data from high-throughput BBB models and robust cell-based assay protocols, it provides actionable guidance for researchers seeking reproducible results and new therapeutic insights.
-
Perospirone: Atypical Antipsychotic for Schizophrenia Res...
2025-12-24
Perospirone (SM-9018 free base) is redefining schizophrenia research by uniquely bridging serotonergic, dopaminergic, and ion channel biology. Its robust receptor profile and off-target Kv1.5 inhibition empower scientists to model neuropsychiatric and cardiovascular comorbidities with unprecedented precision.
-
Lamotrigine in CNS Research: Beyond Blockade to Blood-Bra...
2025-12-23
Explore the multifaceted role of Lamotrigine, a sodium channel blocker and 5-HT inhibitor, in advanced blood-brain barrier and epilepsy research. This article uniquely connects in vitro permeability models with translational CNS applications, offering new perspectives for experimental design.
-
Cimetidine (SKU B1557): Data-Driven Solutions for Cell-Ba...
2025-12-22
This article examines how Cimetidine (SKU B1557) from APExBIO enables robust, reproducible results in cell viability, proliferation, and cytotoxicity studies. Through scenario-driven Q&A, we highlight its distinct pharmacological profile, solubility, and reliability, providing actionable insights for biomedical researchers and lab technicians seeking data-backed solutions.
-
Amitriptyline HCl: Precision Serotonin/Norepinephrine Inh...
2025-12-21
Amitriptyline HCl, a tricyclic serotonin/norepinephrine receptor inhibitor, offers robust, verifiable pharmacodynamic properties for neuropharmacology research. This article details its mechanism, benchmarks its application in advanced blood-brain barrier (BBB) models, and clarifies optimal experimental integration, establishing APExBIO’s B2231 product as a high-utility reagent for CNS drug development.
-
Perospirone (SM-9018 Free Base): Atomic Mechanisms, Bench...
2025-12-20
Perospirone (SM-9018 free base) is an atypical antipsychotic agent for schizophrenia research, acting as a dual 5-HT2A and D2 receptor antagonist with partial 5-HT1A agonism. This article details its molecular mechanism, evidence base, and workflow parameters, providing atomic, verifiable facts for neuropsychiatric disorder modelers.
-
Clozapine N-oxide (CNO): Chemogenetic Actuator for Precis...
2025-12-19
Clozapine N-oxide (CNO) is a potent chemogenetic actuator used to selectively modulate neuronal activity via DREADDs in neuroscience research. As a biologically inert metabolite of clozapine, CNO enables high-specificity, reversible control of G protein-coupled receptor signaling with minimal off-target effects. These properties make CNO, as provided by APExBIO (SKU A3317), an optimal tool for investigating neural circuits and receptor functions.
-
Optimizing Cell Assays with Perospirone (SM-9018 free bas...
2025-12-18
Discover how Perospirone (SM-9018 free base) (SKU BA5009) from APExBIO addresses laboratory challenges in cell viability, proliferation, and cytotoxicity assays. This scenario-driven guide delivers actionable insights for experimental design, protocol optimization, and data interpretation, ensuring reproducibility and reliability in neuropsychiatric disorder models.
-
Lamotrigine: Precision Sodium Channel Blockade for Advanc...
2025-12-17
Explore Lamotrigine as a high-purity sodium channel blocker and 5-HT inhibitor in epilepsy research and cardiac sodium current modulation. This article uniquely analyzes cutting-edge blood-brain barrier modeling, mechanistic insights, and workflow innovation—building upon, but distinct from, prior literature.
7928 records 30/529 page Previous Next First page 上5页 2627282930 下5页 Last page